Stock Events

Stock Events

Viridian Therapeutics (0K1R.LSE) Q2 2025 Earnings

6MayConfirmed

Q3 2024

Q4 2024

Q1 2025

Q2 2025

-1.15

-1.04

-0.92

-0.81

Details

Expected EPS

-0.966807

Actual EPS

-0.87

Surprise EPS

0.1

Surprise Percent

+10.01%

Description

Viridian Therapeutics (0K1R.LSE) has reported earnings of -0.87 per share for Q2 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.